The science

A cross-sectional survey of 61 customers - 93.4% aged 45+, 45.9% with a musculoskeletal diagnosis - assessed effectiveness, symptom relief among prior sufferers, and outcomes by duration.

The results?

94.5% of rated users found it effective (40.0% very effective). Among prior sufferers, 81.6% reported relief from joint aches and 69.2% from inflammation, concentrated anatomically in the knees, hips and hands. The very-effective rating rose to 50.0% at two years or more. 85% would recommend it.

Mechanistically coherent relief

81.6% joint-pain and 69.2% inflammation relief.

A pattern consistent with curcumin's established anti-inflammatory action.

Cumulative duration-response

Very-effective ratings reached 50.0% at two years or more.

Supporting sustained supplementation for maximal benefit.

High advocacy

85% would recommend it; mean recommendation 8.6 out of 10.

84.5% scored 7 or above.

Of 335 customers who had tried Debloat & Detox, effectiveness, time to relief and symptom-level outcomes were assessed (285 gave a definitive rating).

The results?

Among definitively rated users, 80.7% found it effective. Relief was concentrated in the product's target symptoms - bloating (68.8%) and wind (28.7%). Over half (53.5%) of responders noted relief within two weeks.

Symptom-targeted profile

68.8% bloating and 28.7% wind relief.

A concentrated profile suited to bloating-dominant presentations.

Positioned alongside Gut Works®

80.7% positive versus 83.0% for Gut Works®.

Gut Works® suits broader multi-symptom cases; Debloat & Detox® is bloating-focused.

Rapid onset in responders

53.5% within two weeks; 73.5% within three.

For those who respond, relief tends to come early.

A cross-sectional customer survey of 146 consistent users - 79.5% with regular or severe baseline gut and IBS (irritable bowel syndrome) symptoms – assessed effectiveness, symptom-level relief among prior sufferers, and outcomes by duration of use.

The results?

Among definitively rated users, 95.0% found Gut Works® effective (46.8% extremely effective). A clear duration-response emerged: extremely-effective ratings rose from 30.8% at under two months to 58.8% at four months or more, with combined-positive reaching 97.6%. Symptom relief among prior sufferers reached 66.1% (diarrhoea), 62.9% (bloating) and 60.5% (wind) - the most common symptoms of IBS. 90% would recommend Gut Works®.

Duration-dependent efficacy

Extremely-effective ratings rose from 30.8% to 58.8% across duration bands.

Consistent with the biology of microbiome establishment over sustained supplementation.

Relief concentrated in prior sufferers

62.9% bloating, 66.1% diarrhoea, 60.5% wind - among those affected at baseline.

Calculated only among users who reported each symptom before use.

Strong real-world advocacy

90% would recommend it; mean recommendation 8.7 out of 10.

From a highly adherent cohort (96.6% daily or most days).

Individual-level cross-tabulation of 978 MenoFriend® users (735 established, 2+ months), with HRT (n=574) as a same-population comparator.

The results?

82.6% of all users and 88.7% of established users rated MenoFriend® effective, versus 68.5% for HRT, with a far lower dissatisfaction rate (17.4% vs 31.5%). A clear duration-response was seen (64.2% at under two months rising to 95.8% at 1-2 years). MenoFriend® outperformed HRT specifically for brain fog (35.0% vs 26.8%).

Favourable vs HRT in this population

88.7% (established) vs 68.5% for HRT; nearly half the dissatisfaction rate.

Note: ~25% of users also used HRT concurrently.

Clear duration-response

Combined-positive rose from 64.2% to 95.8% across duration bands.

Adequate exposure (3+ months) is key to assessing benefit.

Distinct cognitive edge

Brain-fog relief 35.0% vs 26.8% for HRT.

Alongside hot flushes/night sweats (44.8%) and mood (42.4%).

Within a 265-woman survey, PMS Hero® users were assessed for effectiveness and symptom-level relief, mapped against symptom prevalence and disruptiveness.

The results?

90.9% of rated users found PMS Hero® effective (51.5% extremely or very effective). Mood swings - the most prevalent (70.5%) and most disruptive (39.6%) PMS symptom - were relieved in 72.7% of users. Relief spanned all five of the most-disruptive symptoms. PMS Hero® outperformed every self-management strategy assessed.

Targets the lead symptom

72.7% mood-swing relief.

Directly addressing PMS's most prevalent and most disruptive symptom.

Across the disruptive cluster

Relief reported across mood, low mood, sleep, bloating and headaches.

Coverage of all five top-rated disruptors.

Outperforms standard strategies

90.9% positive vs sub-7/10 means for all common remedies.

Including ibuprofen, general supplements, exercise and paracetamol.

A cross-sectional customer survey of 352 highly adherent users (99.7% daily or most days) assessed effectiveness, a duration-stratified analysis, symptom-level relief, time to benefit and a comparison by HRT status.

The results?

94.6% rated PeriMenoFriend® effective (44.3% extremely effective; combined negative just 5.4%). A clear duration-response emerged — extremely-effective ratings rose from 40.2% at under two months to 59.5% at four months or more, with combined-positive reaching 100% in the longest band. 88.9% reported relief in at least one symptom (mean 3.2), most often anxiety/mood swings (55.7%), hot flushes/night sweats (41.8%) and brain fog (39.2%). Among HRT-naïve users, 97.6% found it effective, and onset was rapid (75.8% within four weeks).

Duration-dependent efficacy

Extremely-effective ratings rose from 40.2% to 59.5% across duration bands.

Combined-positive reached 100% beyond four months, supporting sustained daily use.

Broad psychological and vasomotor relief

Anxiety/mood swings 55.7%, hot flushes/night sweats 41.8%, brain fog 39.2%.

Mean 3.2 symptoms relieved per user; 62.5% across three or more.

Strong non-hormonal signal

97.6% effective among the 70.2% who had never taken HRT.

Supporting its role where HRT is unsuitable or unwanted.

Of 1,202 women surveyed, pH Hero® users were assessed for effectiveness, time to relief and symptom-level outcomes, benchmarked against creams/pessaries, supplements and cranberry juice.

The results?

78.7% of rated users found pH Hero® effective; its 38.7% extremely-effective rating was the highest top-box score of any remedy - ahead of creams and pessaries (33.8%) and far ahead of cranberry juice (7.4%). Relief spanned dryness, discomfort and itchiness alongside thrush, UTIs, BV and pH balance; 75% of responders noted benefit within four weeks.

Highest top-box of any option

38.7% extremely effective - above creams/pessaries (33.8%).

And well above probiotics (16.2%) and cranberry juice (7.4%).

Acts on an upstream mechanism

26.4% reported improved overall pH balance.

A common upstream factor across UTIs, BV and thrush.

Spans chronic and recurrent

Dryness 31.9%, itchiness/discomfort 33.3%, thrush 26.4%, UTIs 25.0%.

Covering both daily-living symptoms and recurrent infection.